Literature DB >> 19837595

Synthesis of bis-Schiff bases of isatins and their antiglycation activity.

Khalid Mohammed Khan1, Momin Khan, Muhammad Ali, Muhammad Taha, Saima Rasheed, Shahnaz Perveen, M Iqbal Choudhary.   

Abstract

Bis-Schiff bases 1-27 have been synthesized and their in vitro antiglycation potential has been evaluated. Compounds 21 (IC(50)=243.95+/-4.59microM), 20 (IC(50)=257.61+/-5.63microM), and 7 (IC(50)=291.14+/-2.53microM) showed an excellent antiglycation activity better than the standard (rutin, IC(50)=294.46+/-1.50microM). This study has identified a series of potential molecules as antiglycation agents. A structure-activity relationship has been studied, and all the compounds were characterized by spectroscopic techniques.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19837595     DOI: 10.1016/j.bmc.2009.09.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  20 in total

1.  QM study and conformational analysis of an isatin Schiff base as a potential cytotoxic agent.

Authors:  Ramin Miri; Nima Razzaghi-asl; Mohammad K Mohammadi
Journal:  J Mol Model       Date:  2012-09-29       Impact factor: 1.810

2.  {2-[(3-Bromo-benzyl-idene)amino]-5-chloro-phen-yl}(phen-yl)methanone.

Authors:  M Aslam; I Anis; N Afza; M Safder; S Yousuf
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-10

3.  {5-Chloro-2-[(4-nitro-benzyl-idene)amino]-phen-yl}(phen-yl)methanone.

Authors:  M Aslam; I Anis; N Afza; A Nelofar; S Yousuf
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-05

4.  {5-Chloro-2-[(2-hy-droxy-benzyl-idene)amino]-phen-yl}(phen-yl)methanone.

Authors:  M Aslam; I Anis; N Afza; A Nelofar; S Yousuf
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-25

5.  Induction of anxiolytic, antidepressant and analgesic effects by Shiff base of (E)-3-(1H-imidazol-4-yl)-2-((2-oxoindolin-3-ylidene)amino)propanoic acid derivatives in diabetic rats.

Authors:  Mohaddese Goleij; Leila Youseftabar-Miri; Maryam Montazeri; Fatemeh Khakpai
Journal:  J Diabetes Metab Disord       Date:  2021-01-03

6.  2-[(E)-(Naphthalen-2-yl)imino-meth-yl]phenol.

Authors:  Hafiz Muhammad Adeel Sharif; Dildar Ahmed Alvi; S Yousuf
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-04

7.  (3,4-Dimeth-oxy-phen-yl)[2-(thio-phen-2-ylcarbon-yl)phen-yl]methanone.

Authors:  G Ganesh; R Sivasakthikumaran; E Govindan; A K Mohana Krishnan; A Subbiahpandi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-09-05

8.  3-(2-Ethyl-2-phenyl-hydrazin-1-yl-idene)indolin-2-one.

Authors:  Uzma Ashiq; Rifat Ara Jamal; Hina Ismail; Khalid Mohammed Khan; Sammer Yousuf
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-28

9.  N'-[(E)-2,3-Dihy-droxy-benzyl-idene]-2-meth-oxy-benzohydrazide.

Authors:  Muhammad Taha; M Syukri Baharudin; Nor Hadiani Ismail; Syed Adnan Ali Shah; Sammer Yousuf
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-03

10.  2-[(4-Bromo-benzyl-idene)amino]-ethanol.

Authors:  Vashen Moodley; Werner E Van Zyl
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.